News

Fred Hutch2y
Checkpoint Inhibitors | Fred Hutchinson Cancer Center
This research helped to develop two recent FDA-approved checkpoint inhibitor drugs — pembrolizumab (Keytruda®) and nivolumab (Opdivo®) — that are now used to treat melanoma, lung cancer, head and neck ...
Forbes1y
Checkpoint Inhibitors: A New Hope for Cancer Treatment
The FDA approved the first PD-1-targeting monoclonal antibodies in 2014: pembrolizumab and nivolumab. FIGURE 1: A broad timeline of milestones for CTLA-4 and PD-1/PD-L1 checkpoint inhibitors. ...
Business Wire8mon
FDA’s Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI’s Multikine® to Address Major Treatment Gap ... - Business Wire
Current labeling for approved checkpoint inhibitors in the indications evaluated by the FDA’s ODAC include broad approvals for all patients, regardless of PD-L1 expression.
pharmaphorum2d
BMS gets FDA OK for first LAG-3 checkpoint inhibitor
Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab ...
FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous ...
Hosted on MSN9mon
Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting - MSN
Bristol Myers Squibb's (NYSE:BMY) Opdivo (nivolumab) and Merck's (NYSE:MRK) Keytruda (pembrolizumab), two highly popular checkpoint inhibitors used in the treatment of various types of cancer ...
technologynetworks1y
Approved Immunosuppressive Boosts the Effectiveness of Existing Checkpoint Inhibitor Therapies - Technology Networks
While there are multiple checkpoint inhibitors approved to treat different types of cancer, many patients don’t respond or develop resistance to available regiments. A Scripps Research team has now ...
Medscape3y
Checkpoint Inhibitor Proliferation Like 'Wild West,' says FDA - Medscape
The FDA has approved seven checkpoint inhibitors in the last seven years, for more than 85 oncology indications. These drugs are antibodies directed against the programmed death 1 ...
Science Daily1y
A new method for improving checkpoint inhibitor therapy for cancer
Checkpoint inhibitor therapies can be thought of as the molecular 'brake release ... "Ruxolitinib is actually an immunosuppressive drug that's clinically approved for chronic graft-versus ...
Morningstar8mon
FDA’s Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI’s Multikine® to Address Major Treatment Gap for ... - Morningstar
CEL-SCI Corporation (NYSE American: CVM) today announced the potential positive impact on the clinical development of its immunotherapy Multikine® (Leukocyte Interleukin, Injection)* resulting ...
technologynetworks1y
Approved Immunosuppressive Boosts the Effectiveness of Existing Checkpoint Inhibitor Therapies - Technology Networks
Scripps Research scientists found that a “one-two punch” of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some ...